Statements (49)
Predicate | Object |
---|---|
gptkbp:instanceOf |
genetic disorder
hemoglobin autosomal recessive disease |
gptkbp:alsoKnownAs |
gptkb:Cooley's_anemia
|
gptkbp:characterizedBy |
hepatosplenomegaly
severe anemia bone deformities iron overload ineffective erythropoiesis |
gptkbp:complication |
gptkb:liver_disease
cardiac failure growth retardation endocrine dysfunction |
gptkbp:diagnosedBy |
genetic testing
hemoglobin electrophoresis |
gptkbp:firstDescribed |
gptkb:Thomas_Cooley
1925 |
gptkbp:frequency |
common in Mediterranean populations
rare in North America |
https://www.w3.org/2000/01/rdf-schema#label |
beta-thalassemia major
|
gptkbp:ICD-10_code |
D56.1
|
gptkbp:inheritance |
autosomal recessive
|
gptkbp:mutationAssociatedWith |
gptkb:HBB_gene
|
gptkbp:OMIM |
613985
|
gptkbp:onset |
early childhood
|
gptkbp:prevalence |
gptkb:Middle_East
gptkb:South_Asia gptkb:Southeast_Asia gptkb:Mediterranean_region |
gptkbp:prognosis |
improved survival with modern therapy
reduced life expectancy without treatment |
gptkbp:relatedTo |
gptkb:alpha-thalassemia
gptkb:beta-thalassemia_intermedia gptkb:beta-thalassemia_minor |
gptkbp:riskFactor |
consanguinity
family history of thalassemia |
gptkbp:screening |
newborn screening
prenatal genetic testing |
gptkbp:symptom |
fatigue
jaundice pallor delayed growth dark urine facial bone abnormalities |
gptkbp:treatment |
hematopoietic stem cell transplantation
iron chelation therapy regular blood transfusions |
gptkbp:bfsParent |
gptkb:beta-thalassemia
|
gptkbp:bfsLayer |
6
|